Legacy Health
Approved Hospital Formulary
Pharmacy - Home (sharepoint.com)
Contact Pharmacy
Search by name
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Antineoplastic HD
Non-Antineoplastic HD
Reproductive Risk HD
RCRA
Do Not Crush
Black Box Warning
REMS
Restricted
Do Not Tube List
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
Boards
Report an iCare
Legacy Health
Approved Hospital Formulary
Pharmacy - Home (sharepoint.com)
Contact Pharmacy
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Antineoplastic HD
Non-Antineoplastic HD
Reproductive Risk HD
RCRA
Do Not Crush
Black Box Warning
REMS
Restricted
Do Not Tube List
Webpage Links
Search results for:
emtricitabine/rilpivirine/tenofovir
emtricitabine/rilpivirine/tenofovir
Brand names:
Complera (emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate), Odefsey emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide)
Form
Strength
TABLET, ORAL
200 mg-25 mg-25 mg; 200 mg-25 mg-300 mg
VIEW MORE
HIV Nonnucleoside Reverse Transcriptase Inhibitors
,
HIV Nucleoside and Nucleotide Reverse Transcriptase Inhibitors
CLASS
08180816
,
08180820
Additional Information:
NON-formulary medication
Last updated:
Feb. 24, 2023
Black Box Warning:
Tenofovir: lactic acidosis, severe hepatomegaly; hepB co-infection
Micromedex
CareNotes
UpToDate
Facts & Comparisons
MedLinePlus (Patient Information)
NON-formulary medication